Search Results - Misiukiewicz, Krysztof

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up

    Quality of Life Analysis of HPV-Positive Oropharyngeal Cancer Patients in a Randomized Trial of Reduced-Dose Versus Standard Chemoradiotherapy: 5-Year Follow-Up by Takahashi, Mai, Hwang, Michael, Misiukiewicz, Krysztof, Gupta, Vishal, Miles, Brett A, Bakst, Richard, Genden, Eric, Selkridge, Isaiah, Botzler, John, Virani, Vruti, Moshier, Erin, Bonomi, Marcelo R, Posner, Marshall R

    Published in Frontiers in oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting

    289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting by Marron, Thomas, Kodysh, Julia, Rubinsteyn, Alex, Finnigan, John, Blazquez, Ana, Saxena, Mansi, Meseck, Marcia, O’Donnell, Timothy, Delbeau, Daniela, Galsky, Matthew, Doroshow, Deborah, Miles, Brett, Misiukiewicz, Krysztof, Irie, Hanna, Tiersten, Amy, Parekh, Samir, Posner, Marshall, Wolf, Andrea, Mandeli, John, Hammerbacher, Jeffrey, Donovan, Michael, Brody, Rachel, Gnjatic, Sacha, Schadt, Eric, Friedlander, Philip, Bhardwaj, Nina

    Request full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract LB048: An adjuvant personalized neoantigen peptide vaccine for the treatment of malignancies (PGV-001)

    Abstract LB048: An adjuvant personalized neoantigen peptide vaccine for the treatment of malignancies (PGV-001) by Marron, Thomas Urban, Saxena, Mansi, Bhardwaj, Nina, Meseck, Marcia, Rubinsteyn, Alex, Finnigan, John, Kodysh, Julia, Blazquez, Ana, O'Donnel, Tim, Galsky, Mathew, Doroshow, Deborah, Miles, Brett, Misiukiewicz, Krysztof, Irie, Hanna, Tiersten, Amy, Parekh, Samir, Posner, Marshall, Wolf, Andrea, Mandeli, John, Brody, Rachel, Gnjatic, Sacha, Schadt, Eric, Friedlander, Philip, Hammerbacher, Jeffrey

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract A005: A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers

    Abstract A005: A phase I study of the safety and immunogenicity of a multipeptide personalized genomic vaccine in the adjuvant treatment of solid cancers by Blazquez, Ana B., Rubinsteyn, Alex, Kodysh, Julia, Finnigan, John P., Marron, Thomas, Sabado, Rachel L., Meseck, Marcia, O'Donnell, Timothy J., Hammerbacher, Jeffrey, Donovan, Michael, Holt, John, Mahajan, Milind, Mandeli, John, Misiukiewicz, Krysztof, Genden, Eric M., Milles, Brett A., Khorasani, Hooman, Dottino, Peter R., Irie, Hanna, Tiersten, Amy B., Port, Elisa R., Wolf, Andrea S., Cho, Hern J., Tewari, Ashutosh, Parekh, Samir S., Nair, Sujit, Galsky, Matthew D., Oh, William K., Gnjatic, Sacha, Schadt, Eric E., Friedlander, Phillip A., Bhardwaj, Nina

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: